Eurordis - Rare Disease Europe

About the EURORDIS Open Academy School on Medicines Research & Development

• Alumni

  To date, more than 400 participants from over 40 countries representing more than 75 diseases have participated in the EURORDIS Open Academy School on Medicines Research & Development.

  Thanks to capacity-building provided by EURORDIS, alumni members have gone on to become involved in various activities at the European Medicines Agency (EMA), such as Protocol Assistance, and to participate in activities related to the European Network for Health Technology Assessment (EUnetHTA).

  Open Academy School on Medicines Research & Development alumni report an increased awareness of the importance of their involvement in all aspects of medicines development and of their potential to be a real force at the European and national levels.

• History of the School

  The first School was launched in 2008 and was originally developed to fill specific needs identified by expert patients, EURORDIS and the European Medicines Agency.

  Expert patients from EURORDIS are permanent representatives on EMA Scientific Committees and working parties, for example, the Committee for Orphan Medicinal Products, the Patients’ and Consumers’ Working Party and the Scientific Advice Working Party.

  EURORDIS, therefore, created the Open Academy School on Medicines Research & Development (formerly Summer School) in recognition of patients’ needs for support and training that includes an overview of clinical research and methodology, medicines development and regulatory procedures.

• Financial support

  The EURORDIS Open Academy School on Medicines Research & Development receives funding under ERDERA.

  ERDERA has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement N°101156595. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or any other granting authority, who cannot be held responsible for them.